March 15, 2022

Proteon Pharmaceuticals appoints sales director for India subcontinent and Southeast Asia

In line with its expansion plans, Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, has announced the appointment of Dr. Sachin Ingewar as regional sales director for the Indian subcontinent and Southeast Asia.

Dr. Ingewar will drive Proteon's growth strategies across the regions to support the poultry industry in achieving safe and sustainable production.

Proteon Pharmaceuticals focuses on precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.

As a poultry nutritionist with over 20 years of comprehensive experience in sales and marketing, Dr. Ingewar has been highly successful in spearheading business in the industry through sustained revenue growth, specifically in the Southeast Asian markets.

Having a strong technical knowledge and expertise in strategic planning and execution, together with account management focused on precise pre- and post-sales efforts, Dr Sachin has been known for improving organisational performance and unlocking new business opportunities through strategic alliances with key decision makers. According to Proteon, he is a visionary who drives revenues and rapid growth profitability with a focus on building a strong corporate culture.

Dr. Ingewar has completed his Masters in Animal Nutrition with Poultry Major.

Elaborating on his new role at Proteon Pharmaceuticals, Dr. Ingewar said: "This leadership role at Proteon is to develop our business in bacteriophages (in the Indian subcontinent and Southeast Asia) and strengthen the presence of Proteon in the region. Our aim is to help poultry, aqua and the ruminant industry to achieve safe and sustainable production. We aim to build awareness about a need to reduce the usage of antibiotics in animal production. All in all, we are here to stay "care for all": environment, humans and animal wellbeing."

Commenting on Dr. Ingewar's appointment, Dr. Paolo Doncecchi, global sales director of Proteon Pharmaceuticals, said: "I am excited about this critical addition to our ISC Proteon organisation. Dr. Sachin will bring market knowledge, business acumen and empathic approach to people. Together, we will bring Proteon to new heights by serving customer needs."

Proteon Pharmaceuticals SA is a global leader in bacteriophage (phage) technology for livestock farming and aquaculture. The company's mission is to eliminate unnecessary antibiotic use, thus reducing the risk of antimicrobial resistance as well as to increase the sustainability of protein production through reduction of waste and improvement of on-farm efficiency.

Proteon's products function by modulating the microbiome enabling prophylactic health. The company has patented a precision phage product development platform using genomics technologies, molecular biology, bioinformatics and artificial intelligence to create effective, reliable and safe antibacterial solutions for animal and human health.

- Proteon